NYXOAH SA - ORDINARY S

Publication relating to a transparency notification

19 Jul 2021 15:30:00 By Nasdaq GlobeNewswire

Publication relating to a transparency notification

14 Jul 2021 15:30:00 By Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

09 Jul 2021 15:30:00 By Nasdaq GlobeNewswire

Nyxoah Announces Closing of Nasdaq Initial Public Offering and Underwriters’ Full Exercise of Option to Purchase Additional Shares

08 Jul 2021 15:30:00 By Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

07 Jul 2021 15:30:00 By Nasdaq GlobeNewswire

Nyxoah Announces Pricing of Nasdaq Public Offering

02 Jul 2021 07:40:27 By Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

29 Jun 2021 12:00:00 By Nasdaq GlobeNewswire

Nyxoah Announces Launch of Proposed Public Offering in the United States

25 Jun 2021 05:30:00 By Nasdaq GlobeNewswire

Nyxoah Issues First Quarter 2021 Results

10 Jun 2021 16:46:43 By Nasdaq GlobeNewswire

Nyxoah files Registration Statement for Proposed Initial Public Offering in the United States

10 Jun 2021 16:41:43 By Nasdaq GlobeNewswire

Nyxoah BETTER SLEEP Trial Reaches its Primary Endpoints

07 Jun 2021 00:00:00 By Nasdaq GlobeNewswire

Publication relating to a transparency notification

26 May 2021 12:25:33 By Nasdaq GlobeNewswire

Invitation to attend the annual shareholders’ meeting of the Company to be held on 9 June 2021

07 May 2021 00:00:00 By Nasdaq GlobeNewswire

Nyxoah Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States

19 Apr 2021 00:02:35 By Nasdaq GlobeNewswire

Nyxoah Reports Full Year 2020 Results

08 Apr 2021 23:57:16 By Nasdaq GlobeNewswire

Nyxoah to Delay Full Year 2020 Earnings Release Until April 9, 2021  

02 Apr 2021 00:02:48 By Nasdaq GlobeNewswire

Nyxoah announces the publication of first positive clinical data in an OSA patient suffering from Complete Concentric Collapse (CCC)

02 Mar 2021 23:58:24 By Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

25 Feb 2021 11:00:28 By Nasdaq GlobeNewswire

Nyxoah to present at the Oppenheimer 31st Annual Healthcare Conference

24 Feb 2021 00:01:35 By Nasdaq GlobeNewswire

Nyxoah receives FDA approval for full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)

09 Feb 2021 00:00:13 By Nasdaq GlobeNewswire